Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025
Collaborative Development of Ultra-Compact and Lightweight Satellite Communication User Terminals for Mobility with Mitsubishi Chemical, NICT, and TECHLAB
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Eisai Listed for 24th Consecutive Year in FTSE4Good Index Series, an Index for Socially Responsible Investment
Prototype divertor outer vertical target for the ITER fusion experimental reactor is completed and the sample has passed the ITER Organization’s certification test
Mitsubishi Motors to Terminate Its Joint Venture Partnership with Shenyang Aerospace Mitsubishi Motors Engine Manufacturing
Eisai To Present Four-Year Efficacy And Safety Data On Continuous Treatment With Lecanemab At The Alzheimer’s Association International Conference 2025
Sapient Intelligence Open-Sources Hierarchical Reasoning Model, a Brain-Inspired Architecture that Solves Complex Reasoning Tasks with 27 Million Parameters
ShrimpTech JIRCAS and IMT Engineering Announce Strategic Collaboration to Advance Land-Based Aquaculture